Blood myeloid cells are known to be dysregulated in coronavirus disease 2019 (COVID-19),
caused by SARS-CoV-2. It is unknown whether the innate myeloid response differs with …

Limited experimental evidence bridges nutrition and cancer immunosurveillance. Here, we
show that ketogenic diet (KD)—or its principal ketone body, 3-hydroxybutyrate (3HB), most …

The circulating metabolome provides a snapshot of the physiological state of the organism
responding to pathogenic challenges. Here we report alterations in the plasma metabolome …

Intestinal microbiota have been proposed to induce commensal-specific memory T cells that
cross-react with tumor-associated antigens. We identified major histocompatibility complex (…

Mucosal-associated invariant T (MAIT) cells are abundant T cells with unique specificity for
microbial metabolites. MAIT conservation along evolution indicates important functions, but …

Over the past 16 years, three coronaviruses (CoVs), severe acute respiratory syndrome
CoV (SARS-CoV) in 2002, Middle East respiratory syndrome CoV (MERS-CoV) in 2012 and …

Whether gut dysbiosis promotes tumorigenesis and how it controls tumor progression remain
open questions. We show that 50% of transplantable extraintestinal malignancies triggered …

Background The development of immune checkpoint blockade (ICB) has revolutionized the
clinical outcome of renal cell carcinoma (RCC). Nevertheless, improvement of durability and …

Patients with cancer are at higher risk of severe coronavirus infectious disease 2019 (COVID-19),
but the mechanisms underlying virus–host interactions during cancer therapies remain …

In patients with bladder cancer treated with neoadjuvant pembrolizumab, E. coli –specific
CXCL13 producing T FH and IgG constitute biomarkers that predict clinical benefit. Beyond its …